What US–UK Agreement on pharmaceuticals and tariff measures means for diagnostics

Last week, the UK and US Government's signed a pharmaceuticals and tariff deal which secured a 0% tariff on all pharmaceutical exports to the US for at least three years. This marks a further step in the UK-US Economic Prosperity deal, signed in May. Most importantly for UK IVD companies, the deal confirms 'preferential terms' for the UK’s MedTech exports…